ProQR

PRQR NASDAQ
11.72
+0.71
+6.45%
盘后: 11.60 -0.12 -1.02% 18:22 06/17 EDT
开盘
10.82
昨收
11.01
最高
12.00
最低
10.82
成交量
10.74万
成交均量(3M)
16.76万
52周最高
24.00
52周最低
6.25
换手率
0.25%
市值
5.06亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供ProQR PRQR股票价格,ProQR股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

ProQR Therapeutics N.V. (ProQR), formerly ProQR Therapeutics B.V., is a pre-clinical stage biopharmaceutical company based in the Netherlands. The Company is engaged in the discovery and development of ribonucleic Acid (RNA)-based therapeutics for the treatment of severe genetic disorders. It designs its therapeutic candidates to specifically target and repair the defective messenger RNA, or Messenger Ribonucleic Acid (mRNA), that is transcribed from a mutated gene in order to restore the expression and function of normal, or wild-type protein. Its product candidates include QR-010, an RNA-based oligonucleotide for the treatment of cystic fibrosis (CF), QR-110, an oligonucleotide and for the treatment of Leber’s congenital amaurosis (LCA).
展开 >

最近浏览

名称
价格
涨跌幅